Article | Open | Published:

In Silico before In Vivo: how to Predict the Heating Efficiency of Magnetic Nanoparticles within the Intracellular Space

Scientific Reports volume 6, Article number: 38733 (2016) | Download Citation



This work aims to demonstrate the need for in silico design via numerical simulation to produce optimal Fe3O4-based magnetic nanoparticles (MNPs) for magnetic hyperthermia by minimizing the impact of intracellular environments on heating efficiency. By including the relevant magnetic parameters, such as magnetic anisotropy and dipolar interactions, into a numerical model, the heating efficiency of as prepared colloids was preserved in the intracellular environment, providing the largest in vitro specific power absorption (SPA) values yet reported. Dipolar interactions due to intracellular agglomeration, which are included in the simulated SPA, were found to be the main cause of changes in the magnetic relaxation dynamics of MNPs under in vitro conditions. These results pave the way for the magnetism-based design of MNPs that can retain their heating efficiency in vivo, thereby improving the outcome of clinical hyperthermia experiments.


As any other therapeutic protocol, magnetic fluid hyperthermia (MFH) aims to achieve the maximum therapeutic effect with the minimum concentration of heating agent. This goal requires precise a priori knowledge of the in vivo heating capacity of such agents as magnetic nanoparticles (MNPs). The bottom line is that the magnetic and rheological properties of magnetic colloids in the as prepared state are different from those in the intracellular environment, particularly because agglomeration disturbs MNP magnetic relaxation mechanisms and thus affects the heating efficiency. MFH consists of heating a target tissue or cell to a temperature of 43–48 °C1,2. The heating mechanism is based on the magnetic losses of previously internalized MNPs under the action of an alternating magnetic field (AMF)3. Thus far, the magnetic materials most extensively used in clinical and biomedical applications are two phases of iron oxide with a spinel structure, i.e., Fe3O4 (magnetite) and γ-Fe2O3 (maghemite). As such, the physical properties and systemic toxicity of these MNPs are well understood. Thus, it is not surprising that these iron oxide MNPs have also been the materials most used for MFH experiments. Although many studies have dealt with the heating mechanisms of these MNPs in colloidal form, only a few have quantitatively examined the mechanisms by which heating efficiency is systematically lower under in vitro or in vivo conditions (i.e., after cell internalization) and related to physical and rheological parameters considered when designing optimal heating materials for therapeutic applications4,5,6.

The origin of power absorption in single-domain MNPs under an AMF is essentially the dephasing between the magnetic moment of MNPs and the magnetic component of the AMF7,8. The net magnetic moment of the single-domain MNPs couples to the magnetic field component of the applied AMF, absorbing energy and transforming it into heat by a thermally assisted relaxation process9. This mechanism accounts for essentially all the heat generated by single-domain particles at the low frequencies of MFH experiments (i.e., ranging from 105–106 Hz). The physical parameter that measures the heating efficiency is the specific power absorption (SPA), also known as specific loss power (SLP), which is the power absorbed/released per unit mass of a magnetic material. As the SPA must be maximized to use magnetic colloids for MFH applications, the design of the constituent MNPs requires a theoretical model of their power absorption to identify those magnetic parameters (e.g., dipolar interactions, composition, magnetic anisotropy) governing the SPA under a given experimental situation. This theoretical model should also include the mechanisms by which physicochemical parameters (e.g., viscosity, dielectric constant, hydrophobicity) of the media surrounding the MNPs affect magnetic relaxation and thus SPA values10.

Two main magnetic relaxation mechanisms determine the dephasing of the magnetic moment during power absorption, i.e., a mechanical process (Brownian relaxation) by which the MNPs rotate with their magnetic moment fixed at a given crystal axis, and a magnetic process (Néel relaxation) by which the magnetic moments fluctuate without MNP rotation. Theoretical approaches for modelling these mechanisms have been discussed8,11,12, and there is presently a consensus8 that Néel relaxation is the dominant process when the effective magnetic anisotropy constant Keff of the MNPs is Keff 1 × 104 J/m3 (as for Fe3O4) and in moderately viscous environments with viscosities η ≥ 0.4 mPa*s (for pure water at room temperature η = 1.0 mPa*s)7,13. The effects of both the magnetic and rheological conditions on SPA can be merged into a single parameter, , such that in those experimental situations where an is obtained, Néel relaxation will be the main contributor to power absorption. For both relaxation mechanisms will contribute simultaneously and, for , the Brown relaxation will dominate the heating relaxation mechanism.

Because the ability to generate heat inside cells depends on which relaxation mechanisms4,14 actually take place within the cell environment (as illustrated in Fig. 1), the challenge of designing intracellular hyperthermia therapy is optimizing the SPA for the dissimilar conditions existing in different tissues and cell types3,15.

Figure 1
Figure 1

Schematic representation of the experimental approach for determining the contributions of relaxation mechanisms, i.e., Néel relaxation (τN) and Brownian rotation (τB), in single-domain particles in water (A), culture medium (B) and cytoplasm (C).

The SPA under in vitro (or in vivo) conditions varies substantially from that in as prepared colloids mostly because when MNPs are taken up by cells, Brown relaxation is drastically stalled, becoming a negligible contribution to heating due to the high viscosity environment, bonding to cell membranes, increased hydrodynamic diameter (e.g., protein corona) and agglomeration. Indeed, a recent work by Soukup et al. has elegantly demonstrated that the blocked Brownian relaxation of internalized MNPs can be reversed by lysing the cells4. The intracellular viscosity has been reported to be as high as η = 50–140 mPa.s16,17, and since

this value alone would account for at least a ≈100-fold increase in the Brown relaxation time compared to the water-based colloid. Hampered MNP free rotation under in vitro conditions due to MNP-cell interactions and/or agglomeration13 would be plausible explanations for systems with high anisotropy failing to produce large amounts of heat, when the applied magnetic field is not large enough to overcome the anisotropy energy barrier.

Particle agglomeration during cell uptake can also significantly alter Néel relaxation through changes in the anisotropy energy barrier due to dipolar interactions; thus, the validity of the Linear Response Theory (LRT) can no longer be simply extrapolated to predict the SPA under in vitro experimental conditions. Previous theoretical and experimental data have demonstrated the influence of particle-particle interactions on the expected SPA18 for agglomerated MNPs in the non-linear region (i.e., when the applied field amplitude H0 is comparable to the anisotropy field HA). These interactions, which can be negligible within protein-rich agglomerates due to surface proteins physically repelling the magnetic cores, can become important in the intracellular space due to the loss of the protein corona, which decreases the average interparticle distance.

This work presents a detailed study of the heating efficiency (i.e., the SPA) of magnetite-based colloids designed to maximize the Néel relaxation under in vitro conditions by using a numerical model of SPA mechanisms, including both the observed in vitro physicochemical conditions and the effects of H0 in the non-LRT region. The magnetic and rheological parameters of the MNPs introduced into the numerical simulation includes (a) dipolar interparticle interactions originating from the agglomeration of MNPs and (b) the viscosity conditions in the intracellular space. Based on these a priori considerations, the two types of magnetic colloids prepared to match the requirements (e.g., average particle size, effective magnetic anisotropy) of the constituent MNPs for heating in vitro resulted in the largest SPA values yet reported for in vitro conditions.

Results and Discussion

Physical and Magnetic Characterization

The magnetic colloids synthesized for this work were obtained through an oxidative hydrolysis method modified by the in situ addition of a polymer that controls the final particle size and provides a selectable functional surface19. Two different polymers, i.e., poly(ethyleneimine) (PEI, MW = 25 kDa) and poly(acrylic acid) (PAA, MW = 450 kDa), were selected to coat MNPs in this work and provide as prepared MNPs with different surface charges. The resulting average size of the magnetic cores obtained were <d> = 25 ± 5 nm and 32 ± 6 nm for the PEI-MNPs and PAA-MNPs, respectively. Table S1 and Figure S1 in the supplementary information summarize the basic physical properties of these MNPs. Regarding the magnetic properties, the saturation magnetization MS of PEI-MNPs and PAA-MNPs obtained from SQUID measurements at 300 K were 51 and 54 Am2/kg, respectively (Figure S2, Supplementary Information).

The anisotropy field HA was determined from direct ferromagnetic resonance (FMR) measurements (Fig. 2) through the angular dependence of the resonance field Hres in oriented samples20. The upper panels (a and b) of Fig. 2 correspond to the PEI-MNPs having an average core size of 26 nm, and the lower panels (c and d) show the corresponding data for the PAA-MNPs with an average size of 32 nm. The data from Fig. 2 show an evident uniaxial symmetry of the magnetic anisotropy, demonstrated by the linear dependence of Hres with cos2(θ) (right panels, b and d), where θ is the orientation of the sample with respect to the applied field. We recall here that FMR measurements were performed on oriented samples (drying under an external magnetic field of H = 636.6 kA/m),

Figure 2
Figure 2

The angular dependence of the resonance field Hres for (a) PEI-MNPs and (c) PEI-MNPs. The linear fit of Hres versus cos2(θ) for (b) PEI-MNPs and (d) PAA-MNPs.

Although the anisotropy fields HA of both types of MNPs revealed the same uniaxial symmetry, the larger anisotropy found for PEI-MNPs (HA = 34.5 kA/m) than for PAA-MNPs (HA = 14 kA/m) is probably associated to the high fields used in FMR measurements (H ≈ 250 kA/m), which are much larger than those used in SPA experiments (H0 ≤ 24 kA/m). These larger fields under FMR experimental conditions make small size differences between samples relevant regarding internal magnetic modes during magnetization reversion, yielding different effective magnetic anisotropies.

Hyperthermia Experiments

The power absorbed by an ensemble of monodisperse, noninteracting MNPs is expected to follow the relation

where χ0 is the initial zero field equilibrium susceptibility; B = 2πτ and λ  = 2 if the LRT conditions are satisfied8,12. Figure 3 shows the SPA(H0) dependence of both colloids as prepared in water as a function of applied field amplitude from H0 = 12 to 23.9 kA/m at fixed f = 560 kHz. The SPA experimental data were fitted with the power law from equation (2) (SPA = Φ·H0λ) with Φ and λ as free parameters (dashed lines in Fig. 3). As discussed in the introduction, the Ω = Keff/η values derived from HA and ηH2O of these colloids imply that Néel relaxation should be the dominant process. We recall that the HA and H0 values of our experiments invalidate the LRT approximation (i.e., a value of λ = 2), at least for the largest H0 amplitudes used. Accordingly, Fig. 3a shows that the H-dependence of the SPA for both types of MNPs deviates from an SPA H2 function and follows an Hλ function, with λ = 3.6 ± 0.1 and λ = 4.8 ± 0.3 for PEI-MNPs and PAA-MNPs, respectively. The λ > 2 values can be understood because approaching the H0 ≈ HA condition means that the area under the M-H hysteresis loop increases more quickly and in a non-linear manner, resulting in the λ values observed for the SPA.

Figure 3: SPA(H) dependence on magnetic field H0 for PEI-MNPs (black solid circles) and PAA-MNPs (red open squares) in water, culture medium (DMEM) and in the cell environment after uptake.
Figure 3

Experimental data points were obtained using a commercial device. Dashed lines represent the best-fit curves, as determined by the power equation (see text).

Figure 3b shows the dependence of the SPA(H0) data (f = 560 kHz) for MNPs dispersed in the Dulbecco’s modified Eagle’s medium (DMEM) used in our cell cultures. When compared to the SPA values of as prepared colloids in water, the values observed for the same MNPs dispersed in DMEM were systematically lower. As the viscosity η of both media are quite similar (i.e., ηDMEM = 0.98 mPa.s and ηwater = 1.00 mPa.s at T = 20 °C), the Brownian relaxation given by equation (1) should not be affected. The time evolution of the hydrodynamic radius of MNPs in cell culture is a complex process that is strongly dependent on the surface characteristics of the particles21. In any case, the large increase in the hydrodynamic radius of the MNPs resulting from the formation of a protein corona and agglomeration (Table S1, Supplementary Information) yields hydrodynamic volumes (VH) for which the Brown relaxation no longer contributes to the total SPA.

Using the same power law used for the as prepared colloids, the experimental data of MNPs dispersed in DMEM (Fig. 3b) could be fitted with the λ values 4.3 ± 0.3 (PEI-MNPs) and 6.2 ± 0.4 (PAA-MNPs), which are 20–30% larger than the corresponding found for MNPs in water. This effect can be understood by the steep increase of the M(H) cycles that occurs when approaching the H0 ≈ HA condition discussed above; this effect is related to the Néel contribution and would therefore be more pronounced when Brownian relaxation is absent. The physicochemical characterization of both colloids in water and DMEM indicates that in these conditions, magnetic interactions are not relevant because the as prepared MNPs in water showed hydrodynamic radii compatible with a good dispersion, while the protein corona that forms in DMEM minimizes dipolar interactions by separating the MNPs.

The SPA(f) dependence of both MNPs at fixed H0 = 18.5 kA/m showed the same general characteristics as the field dependence, i.e., smaller SPA values when dispersed in DMEM due to the lack of Brownian relaxation. Because the factor in equation (2) is constant at a fixed H0, a dependence is expected, in agreement with the non-linear dependence of SPA(f) (at H0 = 23.9 kA/m) observed from the experimental data (Figure S3, Supplementary Information).

These non-linear effects with H0 and f discussed above are relevant if the heating response of a colloid is to be extrapolated to the calculation of thermal doses for clinical MFH applications. Moreover, as will be shown below, the effectiveness with which MNPs generate heat under in vitro/in vivo conditions can also be affected by dipolar interactions.

Prior to determining the SPA (H, f) dependence in vitro, the cellular uptake and distribution of the particles were analysed to assess possible differences between the final distributions of positively charged PEI-MNPs and negatively charged PAA-MNPs. The images obtained from transmission electron microscopy (TEM) and focused ion beam scanning electron microscopy (FIB-SEM) showed as a general trend that both MNP types aggregate in large clusters localized within the cytoplasm, as expected (arrows in Fig. 4A and B). A significant fraction of the incubated MNPs were also observed to be attached to the cell membrane (arrows in Fig. 4C and D), and cross-sectional images demonstrated that these agglomerates often extended across the cell membrane into the cytoplasm (see also Figures S4–S6, Supplementary Information). No significant numbers of particles were found within endosomes, as previously described elsewhere21. The location where MNPs form dense aggregates is relevant for understanding the SPA in vitro because these aggregates indicate that magnetic interactions between particles must be included in any model and/or numerical simulation.

Figure 4
Figure 4

TEM (A,B) and FIB-SEM (C,D) images of SH-SY5Y cells incubated with PEI-MNPs and PAA-MNPs for 24 hours. The TEM images of (A) PEI-MNPs and (B) PAA-MNPs show that the internalized particles formed clusters. The FIB-SEM images of the same cells show the presence of dense agglomerates of (C) PEI-MNPs and (D) PAA-MNPs attached to and crossing the cell membrane.

After cell uptake, the SPA of both types of MNPs showed a pronounced drop (Fig. 3C) compared to the as prepared and DMEM-dispersed data. Notwithstanding the smaller SPA values, the values for λ obtained using the same power law were 4.0 ± 0.3 (PEI-MNPs) and 3.9 ± 0.3 (PAA-MNPs), equivalent to the values observed in water and DMEM, within experimental error. Both the lower SPA values and the similar Hλ dependence for the MNPs after uptake are explained by the final intracellular distribution discussed above; the observed compact agglomerates suggest that the protein corona is lost during uptake, increasing the dipolar interactions between particles.

It is worth noting that the SPA values of the PEI- and PAA-MNPs observed after cell uptake were similar (Fig. 3C), despite differences in the way cells uptake negatively and positively charged MNPs. To evidence these differences, the normalized SPA values per cell (in μW/cell) are shown in Fig. 5 as a function of H0 (at f = 560 kHz).

Figure 5: Experimental values of SPA (μW/cell) of MNP-loaded cells as a function of field amplitude (f = 560 kHz).
Figure 5

PEI-MNP (filled circles) and PAA-MNP (filled stars) values are compared to simulated SPA values (open symbols). Lower panels display simulated hysteresis loops at selected H0 values (points A, B and C).

The analysis of the SPA per cell (μW/cell) allows the inclusion of the impact of cell uptake for a given MNP type on the final heating efficiency. We note that the experiments were designed to have similar numbers of cells within the pellets because, as already discussed, heat dissipation depends critically on sample volume. The SPA of both types of MNPs was sufficient to not only reach the hyperthermic temperature range in this tumour-like environment (i.e., cell pellets having 7 × 106 cells in a volume of 100 μL) but also induce controlled amounts of cell death. The SPA in a single cell was higher with both particles than previously reported values22,23. In high fields, the SPA of the PEI-MNPs becomes saturated at approximately 65 μW/cell, which was not observed for the PAA-MNPs, despite the latter having a smaller SPA value.

To interpret these results, we performed numerical simulations considering an interacting nanoparticle system under the action of an AMF with amplitude H0. From the FMR measurements we estimated the effective anisotropy field values for the two samples in aqueous solution, and these values were used as input for the numerical simulations, to reproduce the experimental SPA of as prepared and in vitro conditions. The numerical values obtained were similar to those obtained from FMR measurements, and were between those values expected for the magneto-crystalline anisotropy of bulk maghemite and the magnetite. These results together with the size of the MNPs indicate that the anisotropy field does not change significantly. Nevertheless, an increment of the magnetic interparticle interaction energy is expected from the agglomeration. A dipolar field between two nanoparticle very close (as evidenced from TEM images) was estimated to be about 900 Oe, indicating that a random local orientation of individual magnetic moments and specific topographic details of MNPs within a cluster do not inevitably imply a reduced value for the effective interaction field. The calculations are based on a model we previously proposed18 that incorporates the dipolar field interaction into the SPA calculations through a mean field approximation. The simulations were performed using the expression for the magnetization M:

where the brackets indicate the thermal statistical average of the magnetization in the superparamagnetic (SP) and blocked (B) regimes. L is the probability to find the particle in the superparamagnetic regime and indicates the population in the i-th minimum. The evolution of the magnetization was computed considering that the field H0 sweeps changing the probability L and the thermal statistical average of M. The input parameters were: Ha, MS, the magnetic diameter (core size), the intrinsic relaxation time, and the parameters associated to the dipolar interaction between the particles. The random orientation for the easy axis of the particles was also considered in our calculations.

This approach considers idealized agglomerates in a hexagonal-close-packed (hcp) arrangement of equal spheres and calculates the magnetic energy Ei for the i-th particle located at the centre of the hcp structure from its 12 nearest neighbours. It is worth noting that for a perfectly ordered hcp configuration, the magnetostatic energy can be shown to be Ei = 0, but any real set of spheres with a size distribution will produce distortions in the hcp packing and thus measurable contributions to Ei. All simulations were performed at room temperature (T = 300 K) with an intrinsic relaxation time of τ0 = 10−9–10−10 s at different field amplitudes H0 but a fixed frequency f = 560 kHz to match our experimental conditions. The magnetic diameters of the MNPs used in the calculations were the experimental diameters <d> = 25 ± 5 nm and 32 ± 6 nm (Table S1, Supplementary Information) obtained from the TEM analysis. The dipolar fields were used as free parameters, and the anisotropy field HA values obtained from the FMR experiments for the two types of MNPs were used as initial values for the calculations. The comparison of the measured and calculated SPA values is shown in Fig. 5. The open dots connected by dashed lines are the simulated values, and the right panels show the simulated hysteresis loops of selected data, labelled A, B and C, in the main graph. From these simulations, we found that the interaction fields HA in the mean field approximation were from 2–5% of the corresponding H0 fields in the PEI-MNPs and PAA-MNPs. We think that this result is a consequence of the particle packing (we assumed an interparticle distance of ≈5 nm as consequence of the loss of polymeric coating on each particle). Our simulations accurately reproduced the experimental SPA values and confirmed that the relevant relaxation mechanism is the magnetic process. In turn, the lack of Brownian relaxation agrees with the agglomeration of the MNPs observed both at the cell membrane and in the cytoplasm, as illustrated in Fig. 4 (Figures S4–S6, Supplementary Information).

The saturation of the SPA values observed for PEI-MNPs at high H0 values is due to the fact that somewhere from H0 = 22–24 kA/m, the hysteresis loop at that frequency reaches the irreversibility point, i.e., the M vs. H curves correspond to a major hysteresis loop. The lower panels of Fig. 5 illustrate this behaviour. Importantly, the values used in the simulations for the anisotropy fields HA were those obtained from the FMR data for the PEI-MNPs. In the case of PAA-MNPs, a value of HA = 55 kA/m was needed to obtain good agreement with the SPA vs. H0 data. This value is larger than the HA = 14 kA/m measured via FMR, and this difference is likely due to the different field regimes used in the two experiments; while H0 ≈ 260 kA/m for the FMR experiments, H0 ≤ 24 kA/m for the SPA experiments. Thus, in the SPA experiments, the reversion of the magnetization in PAA-MNPs was coherent because H0 was much lower than HA. In the FMR experiments, the magnetization followed the magnetic field H0 easily by the above-mentioned internal magnetic modes to reverse the magnetization. Many studies have aimed to maximize the SPA as the key parameter for quantifying the efficiency with which MNPs convert absorbed energy into heat24,25,26,27,28,29. However, the SPA is not an intrinsic property of the MNPs or the magnetic colloid; instead, the SPA depends on the applied frequency f and amplitude H0 of the applied magnetic field in a non-trivial way. Moreover, the effect of the viscosity of the liquid carrier must be considered when comparing the SPA of different MNPs. As such, the literature is plagued with considerable confusion on the actual heating performance of MNPs. Indeed, widely different SPA values have been reported, ranging from 10 to 103 W/g25,30,31,32, depending on the magnetic field conditions used (4 < H0 < 100 kA/m and 10 < f < 5 × 104 kHz). In addition, most of the largest values correspond to the as prepared colloids because the contribution of Brown relaxation in a lower viscosity environment adds to the total power absorption. In contrast, a major limitation of heating small tissue volumes or single cells is the lack of sufficient MNP heating efficiency with clinically acceptable values of MNP concentration, field amplitude and frequency. Some attempts to circumvent this limitation have used dangerously high frequencies and/or larger quantities of particles33,34. Table 1 shows a compilation of previously reported in vitro SPA measurements. Although the SPA values of the as prepared colloids in this work are comparable to previously reported values24,35, our in silico design of MNPs based on theoretical simulations allowed the MNPs to retain their SPA under in vitro conditions. Indeed, to the best of our knowledge, these SPA values are the largest values reported under similar (H, f) conditions, as displayed in Table 1, making them the most effective in vitro nanoheaters yet reported36,37. Our findings clearly support the notion that for the adequate use of MNPs as nanoheaters in vitro or in vivo, it is crucial to engineer the MNPs based on the subtle interplay of the magnetic anisotropy, dipolar interactions and viscosity of the environment surrounding the MNPs.

Table 1: Experimental values of specific power absorption (SPA) reported under in vitro conditions in different cell lines.

Our model and the calculations used here are expected to apply for a) single-domain MNPs and b) within the experimental timeframe of hyperthermia measurements. A different, promising approach using multi-core MNPs composed of single-domain units densely packaged into a MNPs nucleus, has been reported by Dennis et al.38 For these MNPs the interparticle interactions should play a major role, and the large and saturation magnetization reported suggest that exchange interactions across boundaries are active to keep the magnetic moments aligned. This possibility of switching on exchange interactions could open new ways to increase the SPA through materials engineering.

In any case, as the observed intracellular heating is often due to the Néel relaxation of the magnetic moment through the energy barrier in an interacting system, detailed models of MNPs agglomerates, together with their experimental characterization, will be most helpful for understanding how to control the thermal dose in therapies requiring magnetic hyperthermia.


Collectively, these results show how two seemingly similar magnetic colloids (in terms of a basic characterization of the magnetic or physicochemical properties) can differ regarding their properties as magnetic nanoheaters for in vitro magnetic hyperthermia. Due to the high intracellular viscosity, the magnetic relaxation is the relevant mechanism to be optimized for improving the SPA when nanoparticles are internalized or attached to the cell membrane. Differences between the nanoparticles in the dependence of the SPA on the amplitude of the applied field are mainly related to differences in the anisotropy field and magnetic diameter of the nanoparticles, which, together with the local viscosity and dipolar interaction, determines the behaviour of MNPs within a tumour microenvironment. Therefore, preliminary knowledge must be acquired via numerical simulation before the best candidates for future in vitro or in vivo magnetic hyperthermia treatments can be chosen. Regarding iron oxide MNPs, their ‘low’ magnetic anisotropy renders the LRT approximation invalid for magnetic fields ≈25 kA/m. The experimental observation of compact MNP aggregates forming after cell uptake pointed to magnetic interparticle interactions as the origin of the lower heating performance in vitro, while numerical modelling allowed the impact of these magnetic dipolar interactions on the SPA to be quantified. These magnetic interactions, together with the anisotropy field of MNPs, determine the actual heating efficiency of MNPs for in vitro hyperthermia experiments.

Materials and Methods


All reagents were commercially available and used as received without further purification. Iron (II) sulphate heptahydrate (FeSO4·7 H2O), sodium hydroxide (NaOH), potassium nitrate (KNO3), sulfuric acid (H2SO4), poly(ethylenimine) (PEI, MW = 25 kDa) and poly(acrylic acid) (PAA, Mw = 450 kDa) were obtained from Sigma-Aldrich.

Synthesis of Magnetic Colloids

Two different magnetic colloids were synthetized via a modified version of the classical oxidative hydrolysis method, i.e., the precipitation of an iron salt (FeSO4) in basic media (NaOH) with a mild oxidant19. The method was modified to produce an in situ polymer coating with PEI of 25 kDa and PAA of 450 kDa during the reaction, yielding PEI-coated MNPs (PEI-MNPs) and PAA-coated MNPs (PAA-MNPs). The synthesis process of both water-based, stable, magnetic ferrofluids containing coated MNPs has been previously described elsewhere21.

Both water-based, stable, magnetic ferrofluids containing coated MNPs were studied to determine various properties, such as the surface charge, the resistance to aggregation and the number of available functional groups on the particle surface, with respect to each polymer21. Both magnetic colloids were similar in average size, which ranged from ≈25–32 nm with a narrow size distribution. The characterization of the properties of MNPs under different conditions (i.e., dispersion media) is decisive for the success of specific applications. The ability of MNPs to adsorb proteins is expected to depend on the physicochemical characteristics and the surface coating; i.e., its affinity for the adsorption of ions, proteins and natural organic materials. The physiological medium will influence nanoparticle properties, such as size, aggregate state, morphology, surface charge, surface composition and magnetic response. Thus, these properties were studied in water and in Dulbecco’s modified Eagle’s medium (DMEM, Lonza S.L., Porriño, Spain) supplemented with foetal bovine serum (15% FBS).

Cell Culture

Human SH-SY5Y neuroblasts (ATCC CRL-2266) were cultured in DMEM and Ham’s F12 (1:1) with 15% FBS, 100 IU/mL penicillin, 100 μg/mL streptomycin and 2 mM L-glutamine. Cells were maintained at 37 °C in a saturated humid atmosphere containing 95% air and 5% CO2. SH-SY5Y cells were incubated with 100 μg/mL of both nanoparticles (PEI-MNPs and PAA-MNPs) overnight. After this incubation, the cells were washed, and the modified DMEM was replaced with ordinary DMEM. Control experiments were performed with growth medium without nanoparticles.

Determination of Iron Content in the Magnetic Colloids and Intracellular Space

The concentration of ferrite nanoparticles in both magnetic colloids was determined from their Fe content by VIS-UV transmission spectrophotometry (Shimadzu UV-160). The protocol is based on the thiocyanate complexation reaction39:

For this determination, the PEI-MNPs and PAA-MNPs were dissolved in HCl 6 M HNO3 (65%) at 50–60 °C for 2 h. Potassium thiocyanate was then added to the Fe3+ solution to form the iron-thiocyanate complex, which has strong absorbance at a wavelength of 478 nm.

Specific Power Absorption Measurements

The specific power absorption (SPA) experiments in different dispersion media (e.g., water, culture media and the intracellular space) were performed in a commercial magnetic field applicator (DM1 applicator, nB Nanoscale Biomagnetics, Spain) using magnetic fields from 3.98 to 23.9 kA/m at several frequencies, ranging from 260 to 832 kHz. Calorimetric experiments were conducted by exposing 1 mL of the magnetic colloid in a vacuum-insulated Dewar connected to a vacuum pump (10−7 mbar). A fibre-optic measuring probe was placed at the centre of the colloid to sense the temperature of the sample. A ‘dead time’ of 3–4 minutes was allowed before each experiment for the samples to reach thermal equilibrium. We approximated the measurement as being adiabatic, i.e., neglecting the heat losses through the container walls. Under this hypothesis, the SPA equation can be written as

where the parameters m and c are the mass and specific heat, and the subindex np and l indicate nanoparticles and liquid, respectively. The SPA value is extracted from the slope of the temperature vs. time curves during the initial t < 30 s interval. This linear fit gives the maximum heating rate (ΔT/Δt)max of the sample [K·s−1]. The error was estimated from the standard deviation of the number N of measurements for each (H0, f) set of values (N > 3 in all cases).

Transmission Electron Microscopy

The distribution and morphology of SH-SY5Y cells incubated with both types of MNPs were analysed by transmission electron microscopy (TEM) using an FEI Tecnai T20 microscope operating at 200 keV. Cell samples were incubated overnight with PEI-MNPs and PAA-MNPs (10 μg/mL). After this incubation, the cells were detached and fixed with 2% glutaraldehyde solution for 2 h at 4 °C, washed three times in cacodylate buffer (pH 7.2), and then treated with potassium ferrocyanide 2.5% and osmium tetroxide 1% for 1 hour at room temperature. After being washed, the cells were dehydrated with increasing concentrations of acetone, i.e., 30% (x2), 50% (x2), 70% (x2), 90% (x2), and 100%. After drying, the samples were embedded in a solution (50:50) of epoxy resin and acetone (100%) overnight and then in 100% epoxy resin for 4–5 h. The sample were dried for 2 days at 60 °C and then cut into 70-nm-thick slices.

Dual-Beam FIB-SEM Analysis

The intracellular distribution of MNPs in conditioned SH-SY5Y neuroblast samples was studied using dual-beam FIB-SEM (Nova 200 NanoLab, FEI Company). SEM images were taken at 5 and 30 kV with a field emission gun column, and a combined Ga-based 30 kV (10 pA) ion beam was used to view single-cell cross-sections. These investigations were completed by energy-dispersive X-ray spectroscopy for the chemical analysis.

Magnetization Measurements

For the magnetization measurements, 1 mg of each sample was dispersed in 100 μL of ethanol and added to an epoxy resin to immobilize the nanoparticles and minimize interparticle interactions during the magnetization measurements with an applied field. The final samples used for the magnetic measurements contained approximately 1% wt. MNPs. The magnetization measurements were made using a commercial VSM magnetometer at 300 K, and the signal was normalized by the mass of material used.

Ferromagnetic Resonance Measurements

Samples used for the ferromagnetic resonance (FMR) measurements were conditioned in a similar manner as described for the magnetic measurements. However, the hardening of the epoxy resin (about 24 hours) was performed under an applied field of 636.6 kA/m to mechanically orient the easy axis of the nanoparticles. The X-band (9.4 GHz) FMR measurements were performed using a Bruker ESP-300 spectrometer at 300 K. The spectra were measured by varying the orientation of each sample with a goniometer with respect to the applied field; θ is the angle between the field cooling direction and the applied field.

Additional Information

How to cite this article: Sanz, B. et al. In Silico before In Vivo: how to Predict the Heating Efficiency of Magnetic Nanoparticles within the Intracellular Space. Sci. Rep. 6, 38733; doi: 10.1038/srep38733 (2016).

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


  1. 1.

    et al. Intracranial Thermotherapy using Magnetic Nanoparticles Combined with External Beam Radiotherapy: Results of a Feasibility Study on Patients with Glioblastoma Multiforme. J. Neuro-Oncol. 81, 53–60, doi: 10.1007/s11060-006-9195-0 (2007).

  2. 2.

    et al. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique. Int. J. Hyperthermia 21, 637–647 (2005).

  3. 3.

    , , & Influence of the aggregation, concentration, and viscosity on the nanomagnetism of iron oxide nanoparticle colloids for magnetic hyperthermia. J. Nanopart. Res. 17, 1–6, doi: 10.1007/s11051-015-2921-9 (2015).

  4. 4.

    , , , & In situ measurement of magnetization relaxation of internalized nanoparticles in live cells. ACS Nano 9, 231–240, doi: 10.1021/nn503888j (2015).

  5. 5.

    et al. Optimization of magnetic labeling process for intracellular hyperthermia in cervical cancer cells. IEEE Trans. Magn. 50, 1–4 (2014).

  6. 6.

    , & Tumour cell toxicity of intracellular hyperthermia mediated by magnetic nanoparticles. J. Nanosci. Nanotechnol. 7, 2933–2937, doi: 10.1166/jnn.2007.668 (2007).

  7. 7.

    et al. Relaxation time diagram for identifying heat generation mechanisms in magnetic fluid hyperthermia. J. Nanopart. Res. 16, 1–11 (2014).

  8. 8.

    & Dynamics of magnetic nanoparticle in a viscous liquid: Application to magnetic nanoparticle hyperthermia. J. Appl. Phys. 112, 023901, doi: 10.1063/1.4737126 (2012).

  9. 9.

    & Introduction to Magnetic Materials. 2nd edn (John Wiley & Sons, 1972).

  10. 10.

    et al. Particle interactions in liquid magnetic colloids by zero field cooled measurements: Effects on heating efficiency. J. Phys. Chem. C 119, 11022–11030 (2015).

  11. 11.

    , & Simple models for dynamic hysteresis loop calculations of magnetic single-domain nanoparticles: Application to magnetic hyperthermia optimization. J. Appl. Phys. 109, 083921, doi: 10.1063/1.3551582 (2011).

  12. 12.

    Heating magnetic fluid with alternating magnetic field. J. Magn. Magn. Mater. 252, 370–374 (2002).

  13. 13.

    , & Optimizing magnetic nanoparticle design for nanothermotherapy. Nanomedicine 3, 831–844 (2008).

  14. 14.

    , , , & Physical contribution of Neel and Brown relaxation to interpreting intracellular hyperthermia characteristics using superparamagnetic nanofluids. J. Nanosci. Nanotechnol. 13, 5719–5725 (2013).

  15. 15.

    et al. Magnetic hyperthermia efficiency in the cellular environment for different nanoparticle designs. Biomaterials 35, 6400–6411 (2014).

  16. 16.

    , , & Molecular rotor measures viscosity of live cells via fluorescence lifetime imaging. J. Am. Chem. Soc. 130, 6672–6673 (2008).

  17. 17.

    et al. Imaging intracellular viscosity of a single cell during photoinduced cell death. Nat. Chem. 1, 69–73, doi: (2009).

  18. 18.

    et al. Heat generation in agglomerated ferrite nanoparticles in an alternating magnetic field. J. Phys. D Appl. Phys. 46, 045002 (2013).

  19. 19.

    et al. Uniform and water stable magnetite nanoparticles with diameters around the monodomain-multidomain limit. J. Phys. D Appl. Phys. 41, 134003 (2008).

  20. 20.

    , & Size and anisotropy determination by ferromagnetic resonance in dispersed magnetic nanoparticle systems. Journal of Magnetism and Magnetic Materials 262, 235–241, doi: (2003).

  21. 21.

    et al. The effect of surface charge of functionalized Fe3O4 nanoparticles on protein adsorption and cell uptake. Biomaterials 35, 6389–6399, doi: (2014).

  22. 22.

    , & Magnetization reversal and specific loss power of magnetic nanoparticles in cellular environment evaluated by AC hysteresis measurement. J. Nanomater. 2015, 9 (2015).

  23. 23.

    et al. Real-time tracking of delayed-onset cellular apoptosis induced by intracellular magnetic hyperthermia. Nanomedicine 11, 121–136, doi: 10.2217/nnm.15.185 (2015).

  24. 24.

    et al. Exchange-coupled magnetic nanoparticles for efficient heat induction. Nat. Nano. 6, 418–422, doi: 19.1038/nchem.120 (2011).

  25. 25.

    et al. Heat production by bacterial magnetosomes exposed to an oscillating magnetic field. J. Phys. Chem. C 115, 18–22, doi: 10.1021/jp104580t (2011).

  26. 26.

    et al. Water-soluble iron oxide nanocubes with high values of specific absorption rate for cancer cell hyperthermia treatment. ACS Nano 6, 3080–3091, doi: 10.1021/nn2048137 (2012).

  27. 27.

    , , , & Studies of magnetite nanoparticles synthesized by thermal decomposition of iron (III) acetylacetonate in tri(ethylene glycol). J. Magn. Magn. Mater. 321, 3093–3098, doi: 10.1016/j.jmmm.2009.05.020 (2009).

  28. 28.

    et al. Synthesis of manganese ferrite/graphene oxide nanocomposites for biomedical applications. Small 8, 3620–3630, doi: 10.1002/smll.201201427 (2012).

  29. 29.

    , & Magnetite ferrofluid with high specific absorption rate for application in hyperthermia. J. Magn. Magn. Mater. 311, 228–233, doi: 10.1016/j.jmmm.2006.11.179 (2007).

  30. 30.

    , & Size-dependant heating rates of iron oxide nanoparticles for magnetic fluid hyperthermia. J. Magn. Magn. Mater. 321, 1947–1950, doi: 10.1016/j.jmmm.2008.12.017 (2009).

  31. 31.

    et al. Mesoscale assemblies of iron oxide nanocubes as heat mediators and image contrast agents. Langmuir 31, 808–816, doi: 10.1021/la503930s (2015).

  32. 32.

    et al. Iron oxide monocrystalline nanoflowers for highly efficient magnetic hyperthermia. J. Phys. Chem. C 116, 15702–15712, doi: 10.1021/jp3025478 (2012).

  33. 33.

    et al. Synthesis and characterizations of manganese ferrites for hyperthermia applications. Mater. Chem. Phys. 143, 305–310, doi: 10.1016/j.matchemphys.2013.08.066 (2013).

  34. 34.

    et al. Design maps for the hyperthermic treatment of tumors with superparamagnetic nanoparticles. PLoS One 8, 14, doi: 10.1371/journal.pone.0057332 (2013).

  35. 35.

    et al. Enhanced magnetic hyperthermia in iron oxide nano-octopods: Size and anisotropy effects. J. Phys. Chem. C 120, 8370–8379 (2016).

  36. 36.

    , & Intracellular heating of living cells through Néel relaxation of magnetic nanoparticles. Eur. Biophys. J. 37, 223–228 (2008).

  37. 37.

    et al. The duality of iron oxide nanoparticles in cancer therapy: Amplification of heating efficiency by magnetic hyperthermia and photothermal bimodal treatment. ACS Nano 10, 2436–2446 (2016).

  38. 38.

    et al. Internal Magnetic Structure of Nanoparticles Dominates Time-Dependent Relaxation Processes in a Magnetic Field. Advanced Functional Materials 25, 4300–4311, doi: 10.1002/adfm.201500405 (2015).

  39. 39.

    & Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials 26, 1565–1573, doi: 10.1016/j.biomaterials.2004.05.022 (2005).

  40. 40.

    et al. Thermosensitivity profile of malignant glioma U87-MG cells and human endothelial cells following [gamma]-Fe2O3 NPs internalization and magnetic field application. RSC Adv. 6, 15415–15423, doi: 10.1039/c5ra22960j (2016).

  41. 41.

    , , & In vitro evaluation of PEGylated mesoporous MgFe 2 O 4 magnetic nanoassemblies (MMNs) for chemo-thermal therapy. J. Mater. Chem. B 1, 3652–3660 (2013).

  42. 42.

    et al. In vitro application of Mn-ferrite nanoparticles as novel magnetic hyperthermia agents. J. Mater. Chem. B 2, 8390–8398, doi: 10.1039/c4tb01017e (2014).

  43. 43.

    et al. Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. J. Am. Chem. Soc. 129, 2628–2635 (2007).

Download references


We are indebted to Dr. T.E. Torres for his help during the dual-beam imaging experiments. This work was supported by the Spanish Ministerio de Economia y Competitividad (MINECO) through project MAT2013-42551. Technical support from LMA-INA and SAI-UZ is acknowledged.

Author information

Author notes

    • Beatriz Sanz

    Present address: nB nanoscale Biomagnetics S.L., Zaragoza, Spain.


  1. Instituto de Nanociencia de Aragón (INA), Universidad de Zaragoza, 50018 Zaragoza, Spain

    • Beatriz Sanz
    • , M. Pilar Calatayud
    • , M. Ricardo Ibarra
    •  & Gerardo F. Goya
  2. Departamento de Física de la Materia Condensada, Facultad de Ciencias, Universidad de Zaragoza, 50009 Zaragoza, Spain

    • M. Pilar Calatayud
    • , M. Ricardo Ibarra
    •  & Gerardo F. Goya
  3. Centro Atómico Bariloche/CONICET, Bariloche, CP 8400, Argentina

    • Emilio De Biasi
    • , Enio Lima Jr.
    • , Marcelo Vasquez Mansilla
    •  & Roberto D. Zysler


  1. Search for Beatriz Sanz in:

  2. Search for M. Pilar Calatayud in:

  3. Search for Emilio De Biasi in:

  4. Search for Enio Lima in:

  5. Search for Marcelo Vasquez Mansilla in:

  6. Search for Roberto D. Zysler in:

  7. Search for M. Ricardo Ibarra in:

  8. Search for Gerardo F. Goya in:


B.S., M.P.C. and G.F.G. designed the experimental protocols. B.S. and M.P.C. synthesized the colloids, managed the cell line experiments and performed the SPA measurements. E.D.B., E.L., M.V.M. and R.D.Z. designed the theoretical cluster model and performed the numerical simulation. M.R.I., R.D.Z. and G.F.G. supervised the experimental and theoretical strategies. All authors participating in the writing and revising of the manuscript.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Gerardo F. Goya.

Supplementary information

About this article

Publication history






By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.